
    
      A single-centre, randomized, double-blind placebo-controlled, dose-ascending, cross-over
      study to evaluate the safety, tolerability, pharmacodynamics and pharmacokinetics of single
      inhaled doses of GSK233705 (50, 100 and 200Âµg), formulated with the excipient magnesium
      stearate, in healthy volunteers.
    
  